Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison

被引:0
|
作者
M. Gorschlüter
C. Hahn
A. Fixson
U. Mey
C. Ziske
E. Molitor
R. Horré
T. Sauerbruch
G. Marklein
I. G. H. Schmidt-Wolf
A. Glasmacher
机构
[1] University of Bonn,Department of Internal Medicine I
[2] University of Bonn,Department of Medical Microbiology and Immunology
来源
Supportive Care in Cancer | 2003年 / 11卷
关键词
Neutropenia; Acute leukemia; Febrile infections; Empiric antibiotic therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:362 / 370
页数:8
相关论文
共 50 条
  • [31] Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients:: results of the COSTINE study
    Sanza, MA
    Bermüdez, A
    Rovira, M
    Besalduch, J
    Pascual, MJ
    Nocea, G
    Sanz-Rodríguez, C
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (05) : 645 - 655
  • [32] Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients - A randomized, double-blind trial
    Peacock, JE
    Herrington, DA
    Wade, JC
    Lazarus, HM
    Reed, MD
    Sinclair, JW
    Haverstock, DC
    Kowalsky, SF
    Hurd, DD
    Cushing, DA
    Harman, CP
    Donowitz, GR
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (02) : 77 - 86
  • [33] Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials
    Wang, Jing
    Zhan, Ping
    Zhou, Rongfu
    Xu, Jingyan
    Shao, Xiaoyan
    Yang, Yonggong
    Ouyang, Jian
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1082 - 1088
  • [34] Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials
    Jing Wang
    Ping Zhan
    Rongfu Zhou
    Jingyan Xu
    Xiaoyan Shao
    Yonggong Yang
    Jian Ouyang
    Medical Oncology, 2010, 27 : 1082 - 1088
  • [35] Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropneia in patients with hematological malignancies
    Shinohara, Akihito
    Yoshiki, Yumiko
    Masamoto, Yosuke
    Hangaishi, Akira
    Nannya, Yasuhito
    Kurokawa, Mineo
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 794 - 798
  • [36] Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia
    Weber, Nicholas
    Jackson, Kathryn
    McWhinney, Brett
    Ungerer, Jacobus
    Kennedy, Glen
    Lipman, Jeffrey
    Roberts, Jason A.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (07) : 503 - 508
  • [37] A RANDOMIZED STUDY OF TEICOPLANIN PLUS CIPROFLOXACIN VERSUS GENTAMICIN PLUS PIPERACILLIN FOR THE EMPIRICAL-TREATMENT OF FEVER IN NEUTROPENIC PATIENTS
    KELSEY, SM
    COLLINS, PW
    DELORD, C
    WEINHARD, B
    NEWLAND, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 : 10 - 13
  • [38] Piperacillin-Tazobactum Plus Amikacin Versus Ceftazidime Plus Amikacin as Empirical Therapy for Fever in Neutropenic Patients with Hematological Malignancies
    Ghalaut, P. S.
    Chaudhary, Uma
    Ghalaut, Veena S.
    Dhingra, Atul
    Dixit, Gaurav
    Aggarwal, Sameer
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2011, 27 (03) : 131 - 135
  • [39] COMPARISON OF MICAFUNGIN AND LIPOSOMAL AMPHOTERICIN B FOR EMPIRICAL ANTIFUNGAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A RANDOMIZED CONTROLLED TRIAL
    Fujisawa, Y.
    Oyake, T.
    Sugawara, N.
    Sasaki, R.
    Tsukushi, Y.
    Hanamura, I.
    Fujishima, Y.
    Aoki, Y.
    Kowata, S.
    Ito, S.
    Ishida, Y.
    HAEMATOLOGICA, 2015, 100 : 135 - 135
  • [40] IMIPENEM CILASTATIN VERSUS PIPERACILLIN PLUS AMIKACIN AS EMPIRIC THERAPY IN THE TREATMENT OF FEBRILE EPISODES IN NEUTROPENIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    VANDERCAM, B
    EZZEDDINE, H
    AGALIOTIS, D
    GALA, JL
    GIGI, J
    WAUTERS, G
    MICHAUX, JL
    ACTA CLINICA BELGICA, 1989, 44 (02): : 99 - 109